TNF and cancer: The cancer-specific apoptotic potential of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has attracted great attention among biologists and oncologists, with some studies using recombinant human TRAIL (rhTRAIL) reaching clinical trials [1].